Publications | Lund University Publications

161 – 170 of 324

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221351-8216%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
16
17
18
19
…
33
next »

2010
Mark Clinical issues in inhibitors
Astermark, Jan ^LU ; Santagostino, E. and Hoots, W. Keith (2010) In Haemophilia 16. p.54-60
- Contribution to journal › Scientific review
Mark A retrospective study: of Octaplex (R) in the treatment of bleeding in patients with haemophilia A complicated by inhibitors
Pock, K. ; Berntorp, Erik ^LU ; Futema, L. ; Knaub, S. ; Walter, O. ; Trawnicek, L. and Roemisch, J. (2010) In Haemophilia 16. p.76-76
- Contribution to journal › Published meeting abstract
Mark Comparison of several automated VWF:RCo assays for monitoring of patients treated with VWF/FVIII concentrates: improved performance with a new modified method
Stadler, M. ; Hillarp, Andreas ^LU ; Janisch, S. ; Zapfl, C. ; Haderer, C. and Schwartz, B. (2010) In Haemophilia 16. p.149-150
- Contribution to journal › Published meeting abstract
Mark The combination of Octaplex (R) and Octanate (R) restores thrombin generation capacity in FVIII inhibitor plasma in-vitro
Berntorp, Erik ^LU ; Pock, K. ; Laher-Kheirallah, I. ; Janisch, S. ; Walter, O. and Roemisch, J. (2010) In Haemophilia 16. p.69-69
- Contribution to journal › Published meeting abstract
Mark FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
Perry, D. ; Berntorp, Erik ^LU ; Tait, C. ; Dolan, G. ; Holme, P. A. ; Laffan, M. ; Lassila, R. ; Mumford, A. ; Pasi, J. and Wilde, J. , et al. (2010) In Haemophilia 16(1). p.80-89
- Contribution to journal › Article
Mark A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data
Leissinger, C. ; Negrier, C. ; Berntorp, Erik ^LU ; Windyga, J. ; Serban, M. ; Bulent, A. ; Lassila, R. ; Kavakli, K. ; Zulfikar, B. and Gringeri, A. (2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.31-31
- Contribution to journal › Published meeting abstract
Mark Considerations in the laboratory assessment of haemostasis
McCraw, A. ; Hillarp, Andreas ^LU and Echenagucia, M. (2010) In Haemophilia 16(s5). p.74-78
- Contribution to journal › Scientific review
Mark A randomized clinical trial on prophylaxis vs. episodic treatment in children with haemophilia A: the ESPRIT study
Gringeri, A. ; Lundin, Björn ^LU ; Von Mackensen, S. ; Mantovani, L. and Mannucci, P. (2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.29-30
- Contribution to journal › Published meeting abstract
Mark Hemophilia A patients without detectable mutations - investigation of disease-associated factors
Ljung, Rolf ^LU ; Knobe, Karin ^LU ; Sjörin, Elsy ^LU ; Nilsson, D. and Hallden, C. (2010) In Haemophilia 16. p.93-93
- Contribution to journal › Published meeting abstract
Mark Management of bleedings in carriers
Tedgård, Ulf ^LU (2010) In Haemophilia 16. p.16-16
- Contribution to journal › Published meeting abstract

« previous
1
…
16
17
18
19
…
33
next »

your query:: Remove issn: 1351-8216